Market Overview:
The global coagulation hemostasis analyzer market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of thrombotic disorders, rising demand for point-of-care testing, and technological advancements in coagulation hemostasis analyzers. Based on type, the global coagulation hemostasis analyzer market is segmented into semi-automatic coagulation hemostasis analyzers and automatic coagulation hemostasis analyzers. The semi-automatic segment is expected to account for a larger share of the global market than the automatic segment during the forecast period. This can be attributed to their lower cost and easy availability as compared to automatic coagulation hemostasis analyzers.
Product Definition:
Coagulation Hemostasis Analyzer is a medical device used to measure the time it takes for blood to clot. The device is important because it can help doctors diagnose and treat problems with blood clotting.
Semi-automatic Coagulation Hemostasis Analyzer:
Semi-automatic hemostasis analyzer is a device used for measuring the level of blood coagulation factors in the patient's sample. It helps to diagnose and treat patients with bleeding disorders, including hemophilia. The major factor driving this market includes growing prevalence of lifestyle associated diseases such as cardiovascular diseases, cancer, and diabetes which are leading to increased demand for diagnostic procedures.
Automatic Coagulation Hemostasis Analyzer:
The automatic coagulation hemostasis analyzer is a medical device used for the measurement of prothrombin time (PT) and international normalized ratio (INR) in the patient's sample. The market for automatic coagulation hemostasis analyzer is driven by factors such as increasing prevalence of chronic diseases, rising demand for point-of-care testing, technological advancements in automated hemostasis instruments and growing awareness about INR monitoring among patients.
Application Insights:
Based on application, the global coagulation hemostasis analyzer market is segmented into research institutes, hospitals and other healthcare facilities, and others. Research institutes held the largest share of over 50% in 2017. The primary factor contributing to this large share is that most of the leading players have their R&D centers at various research institutes across the globe where new products are developed and existing products upgraded. For instance, Siemens Healthineers develops its product line at institutions such as University College London Hospitals National Health Service (NHS) Foundation Trust & King's College Hospital NHS Foundation Trust which subsequently contributes to a significant portion of overall revenue for these analyzers globally.
Hospitals accounted for a substantial revenue share in 2018 owing to factors such as increasing cases of trauma & surgical critical care units resulting in an increased number of surgeries requiring Coagulation Hemostasis Analyzers (CHA).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies, and favorable reimbursement policies. The U.S., which is at the forefront of this region, has a well-developed healthcare infrastructure and highly developed research sector that caters to major parts of the world including Europe and Asia Pacific countries.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to increasing demand for technologically advanced products coupled with rising patient awareness levels regarding various treatment options available for coagulation disorders in this region as compared to other regions globally.
Growth Factors:
- Increasing incidence of bleeding disorders: The global Coagulation Hemostasis Analyzer market is expected to grow at a CAGR of 6.5% during the forecast period owing to the increasing incidence of bleeding disorders such as hemophilia, von Willebrand disease, and others.
- Growing demand for point-of-care testing: The growing demand for point-of-care testing is another major growth driver for the Coagulation Hemostasis Analyzer market. This can be attributed to the advantages offered by these tests over laboratory tests such as faster results and lower costs.
- Technological advancements: The development of novel technologies in coagulation hemostasis analyzers is another key factor driving market growth. These technologies are helping manufacturers offer advanced products with better performance and accuracy levels than ever before.
Scope Of The Report
Report Attributes
Report Details
Report Title
Coagulation Hemostasis Analyzer Market Research Report
By Type
Semi-automatic Coagulation Hemostasis Analyzer, Automatic Coagulation Hemostasis Analyzer
By Application
Research Institutes, Hospitals
By Companies
Stago Group (HemoSonics), Grifols, Haemonetics, Roche Diagnostics, Abbott (Alere), Sysmex Corporation, Nihon Kohden, Thermo Fisher Scientific, Siemens, Helena Laboratories, Instrumentation Laboratory (Werfen), International Technidyne Corporation (ITC)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Coagulation Hemostasis Analyzer Market Report Segments:
The global Coagulation Hemostasis Analyzer market is segmented on the basis of:
Types
Semi-automatic Coagulation Hemostasis Analyzer, Automatic Coagulation Hemostasis Analyzer
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research Institutes, Hospitals
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Stago Group (HemoSonics)
- Grifols
- Haemonetics
- Roche Diagnostics
- Abbott (Alere)
- Sysmex Corporation
- Nihon Kohden
- Thermo Fisher Scientific
- Siemens
- Helena Laboratories
- Instrumentation Laboratory (Werfen)
- International Technidyne Corporation (ITC)
Highlights of The Coagulation Hemostasis Analyzer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Semi-automatic Coagulation Hemostasis Analyzer
- Automatic Coagulation Hemostasis Analyzer
- By Application:
- Research Institutes
- Hospitals
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Coagulation Hemostasis Analyzer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Coagulation Hemostasis Analyzer is a medical device used to measure the coagulation status of patients. The analyzer uses a variety of techniques to assess the level of clotting factors in a patient's blood, and can provide information about the risk of bleeding.
Some of the major companies in the coagulation hemostasis analyzer market are Stago Group (HemoSonics), Grifols, Haemonetics, Roche Diagnostics, Abbott (Alere), Sysmex Corporation, Nihon Kohden, Thermo Fisher Scientific, Siemens, Helena Laboratories, Instrumentation Laboratory (Werfen), International Technidyne Corporation (ITC).
The coagulation hemostasis analyzer market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Coagulation Hemostasis Analyzer Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Coagulation Hemostasis Analyzer Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Coagulation Hemostasis Analyzer Market - Supply Chain
4.5. Global Coagulation Hemostasis Analyzer Market Forecast
4.5.1. Coagulation Hemostasis Analyzer Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Coagulation Hemostasis Analyzer Market Size (000 Units) and Y-o-Y Growth
4.5.3. Coagulation Hemostasis Analyzer Market Absolute $ Opportunity
5. Global Coagulation Hemostasis Analyzer Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Coagulation Hemostasis Analyzer Market Size and Volume Forecast by Type
5.3.1. Semi-automatic Coagulation Hemostasis Analyzer
5.3.2. Automatic Coagulation Hemostasis Analyzer
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Coagulation Hemostasis Analyzer Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Coagulation Hemostasis Analyzer Market Size and Volume Forecast by Application
6.3.1. Research Institutes
6.3.2. Hospitals
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Coagulation Hemostasis Analyzer Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Coagulation Hemostasis Analyzer Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Coagulation Hemostasis Analyzer Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Coagulation Hemostasis Analyzer Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Coagulation Hemostasis Analyzer Demand Share Forecast, 2019-2026
9. North America Coagulation Hemostasis Analyzer Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Coagulation Hemostasis Analyzer Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Coagulation Hemostasis Analyzer Market Size and Volume Forecast by Application
9.4.1. Research Institutes
9.4.2. Hospitals
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Coagulation Hemostasis Analyzer Market Size and Volume Forecast by Type
9.7.1. Semi-automatic Coagulation Hemostasis Analyzer
9.7.2. Automatic Coagulation Hemostasis Analyzer
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Coagulation Hemostasis Analyzer Demand Share Forecast, 2019-2026
10. Latin America Coagulation Hemostasis Analyzer Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Coagulation Hemostasis Analyzer Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Coagulation Hemostasis Analyzer Market Size and Volume Forecast by Application
10.4.1. Research Institutes
10.4.2. Hospitals
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Coagulation Hemostasis Analyzer Market Size and Volume Forecast by Type
10.7.1. Semi-automatic Coagulation Hemostasis Analyzer
10.7.2. Automatic Coagulation Hemostasis Analyzer
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Coagulation Hemostasis Analyzer Demand Share Forecast, 2019-2026
11. Europe Coagulation Hemostasis Analyzer Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Coagulation Hemostasis Analyzer Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Coagulation Hemostasis Analyzer Market Size and Volume Forecast by Application
11.4.1. Research Institutes
11.4.2. Hospitals
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Coagulation Hemostasis Analyzer Market Size and Volume Forecast by Type
11.7.1. Semi-automatic Coagulation Hemostasis Analyzer
11.7.2. Automatic Coagulation Hemostasis Analyzer
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Coagulation Hemostasis Analyzer Demand Share, 2019-2026
12. Asia Pacific Coagulation Hemostasis Analyzer Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Coagulation Hemostasis Analyzer Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Coagulation Hemostasis Analyzer Market Size and Volume Forecast by Application
12.4.1. Research Institutes
12.4.2. Hospitals
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Coagulation Hemostasis Analyzer Market Size and Volume Forecast by Type
12.7.1. Semi-automatic Coagulation Hemostasis Analyzer
12.7.2. Automatic Coagulation Hemostasis Analyzer
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Coagulation Hemostasis Analyzer Demand Share, 2019-2026
13. Middle East & Africa Coagulation Hemostasis Analyzer Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Coagulation Hemostasis Analyzer Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Coagulation Hemostasis Analyzer Market Size and Volume Forecast by Application
13.4.1. Research Institutes
13.4.2. Hospitals
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Coagulation Hemostasis Analyzer Market Size and Volume Forecast by Type
13.7.1. Semi-automatic Coagulation Hemostasis Analyzer
13.7.2. Automatic Coagulation Hemostasis Analyzer
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Coagulation Hemostasis Analyzer Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Coagulation Hemostasis Analyzer Market: Market Share Analysis
14.2. Coagulation Hemostasis Analyzer Distributors and Customers
14.3. Coagulation Hemostasis Analyzer Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Stago Group (HemoSonics)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Grifols
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Haemonetics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Roche Diagnostics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Abbott (Alere)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sysmex Corporation
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Nihon Kohden
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Thermo Fisher Scientific
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Siemens
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Helena Laboratories
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Instrumentation Laboratory (Werfen)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. International Technidyne Corporation (ITC)
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook